![](/img/cover-not-exists.png)
PMS29 Cost Effectiveness of Adalimumab Versus Golimumab and Placebo in Ankylosing Spondylitis in Italy
A. Marcellusi, M.F. Botteman, S. Rao, M. Cifaldi, C.T. Solem, L. Gitto, P. Giannantoni, F.S. MenniniVolume:
15
Year:
2012
Language:
english
DOI:
10.1016/j.jval.2012.08.1384
File:
PDF, 59 KB
english, 2012